nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—ABCB1—ovarian cancer	0.495	1	CbGaD
Desloratadine—ABCB1—Topotecan—ovarian cancer	0.0717	0.235	CbGbCtD
Desloratadine—ABCB1—Vinorelbine—ovarian cancer	0.0506	0.166	CbGbCtD
Desloratadine—CYP2D6—Vinorelbine—ovarian cancer	0.0476	0.156	CbGbCtD
Desloratadine—CYP2C9—Paclitaxel—ovarian cancer	0.0366	0.12	CbGbCtD
Desloratadine—ABCB1—Paclitaxel—ovarian cancer	0.0355	0.116	CbGbCtD
Desloratadine—ABCB1—Docetaxel—ovarian cancer	0.0257	0.0842	CbGbCtD
Desloratadine—ABCB1—Doxorubicin—ovarian cancer	0.0191	0.0628	CbGbCtD
Desloratadine—CYP2D6—Doxorubicin—ovarian cancer	0.018	0.0592	CbGbCtD
Desloratadine—Decreased appetite—Topotecan—ovarian cancer	0.000618	0.00309	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000614	0.00307	CcSEcCtD
Desloratadine—Fatigue—Topotecan—ovarian cancer	0.000613	0.00306	CcSEcCtD
Desloratadine—Dyspepsia—Melphalan—ovarian cancer	0.000613	0.00306	CcSEcCtD
Desloratadine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000608	0.00304	CcSEcCtD
Desloratadine—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000607	0.00303	CcSEcCtD
Desloratadine—Decreased appetite—Melphalan—ovarian cancer	0.000605	0.00302	CcSEcCtD
Desloratadine—Epistaxis—Paclitaxel—ovarian cancer	0.000605	0.00302	CcSEcCtD
Desloratadine—Infection—Vinorelbine—ovarian cancer	0.000604	0.00302	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000601	0.003	CcSEcCtD
Desloratadine—Fatigue—Melphalan—ovarian cancer	0.0006	0.003	CcSEcCtD
Desloratadine—Nervous system disorder—Vinorelbine—ovarian cancer	0.000597	0.00298	CcSEcCtD
Desloratadine—Rash maculo-papular—Epirubicin—ovarian cancer	0.000596	0.00298	CcSEcCtD
Desloratadine—Tachycardia—Vinorelbine—ovarian cancer	0.000594	0.00297	CcSEcCtD
Desloratadine—Hypersensitivity—Chlorambucil—ovarian cancer	0.000588	0.00294	CcSEcCtD
Desloratadine—Gastrointestinal pain—Topotecan—ovarian cancer	0.000581	0.00291	CcSEcCtD
Desloratadine—Anorexia—Vinorelbine—ovarian cancer	0.00058	0.0029	CcSEcCtD
Desloratadine—Asthenia—Chlorambucil—ovarian cancer	0.000573	0.00286	CcSEcCtD
Desloratadine—Pharyngitis—Paclitaxel—ovarian cancer	0.000572	0.00286	CcSEcCtD
Desloratadine—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000566	0.00283	CcSEcCtD
Desloratadine—Pruritus—Chlorambucil—ovarian cancer	0.000565	0.00282	CcSEcCtD
Desloratadine—Urticaria—Topotecan—ovarian cancer	0.000565	0.00282	CcSEcCtD
Desloratadine—Abdominal pain—Topotecan—ovarian cancer	0.000562	0.00281	CcSEcCtD
Desloratadine—Body temperature increased—Topotecan—ovarian cancer	0.000562	0.00281	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000554	0.00277	CcSEcCtD
Desloratadine—Urticaria—Melphalan—ovarian cancer	0.000553	0.00276	CcSEcCtD
Desloratadine—Rash maculo-papular—Doxorubicin—ovarian cancer	0.000551	0.00275	CcSEcCtD
Desloratadine—Diarrhoea—Chlorambucil—ovarian cancer	0.000546	0.00273	CcSEcCtD
Desloratadine—Infestation NOS—Docetaxel—ovarian cancer	0.000544	0.00272	CcSEcCtD
Desloratadine—Infestation—Docetaxel—ovarian cancer	0.000544	0.00272	CcSEcCtD
Desloratadine—Dyspnoea—Vinorelbine—ovarian cancer	0.000542	0.00271	CcSEcCtD
Desloratadine—Cardiac disorder—Paclitaxel—ovarian cancer	0.000534	0.00267	CcSEcCtD
Desloratadine—Decreased appetite—Vinorelbine—ovarian cancer	0.000529	0.00264	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000525	0.00262	CcSEcCtD
Desloratadine—Fatigue—Vinorelbine—ovarian cancer	0.000524	0.00262	CcSEcCtD
Desloratadine—Hypersensitivity—Topotecan—ovarian cancer	0.000524	0.00262	CcSEcCtD
Desloratadine—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000514	0.00257	CcSEcCtD
Desloratadine—Hypersensitivity—Melphalan—ovarian cancer	0.000513	0.00256	CcSEcCtD
Desloratadine—Epistaxis—Docetaxel—ovarian cancer	0.000513	0.00256	CcSEcCtD
Desloratadine—Asthenia—Topotecan—ovarian cancer	0.00051	0.00255	CcSEcCtD
Desloratadine—Vomiting—Chlorambucil—ovarian cancer	0.000508	0.00254	CcSEcCtD
Desloratadine—Increased appetite—Epirubicin—ovarian cancer	0.000507	0.00253	CcSEcCtD
Desloratadine—Mental disorder—Paclitaxel—ovarian cancer	0.000505	0.00252	CcSEcCtD
Desloratadine—Pruritus—Topotecan—ovarian cancer	0.000503	0.00251	CcSEcCtD
Desloratadine—Erythema—Paclitaxel—ovarian cancer	0.000501	0.0025	CcSEcCtD
Desloratadine—Asthenia—Melphalan—ovarian cancer	0.0005	0.0025	CcSEcCtD
Desloratadine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000497	0.00249	CcSEcCtD
Desloratadine—Pruritus—Melphalan—ovarian cancer	0.000493	0.00246	CcSEcCtD
Desloratadine—Hepatitis—Docetaxel—ovarian cancer	0.000488	0.00244	CcSEcCtD
Desloratadine—Diarrhoea—Topotecan—ovarian cancer	0.000487	0.00243	CcSEcCtD
Desloratadine—Pharyngitis—Docetaxel—ovarian cancer	0.000484	0.00242	CcSEcCtD
Desloratadine—Urticaria—Vinorelbine—ovarian cancer	0.000483	0.00241	CcSEcCtD
Desloratadine—Body temperature increased—Vinorelbine—ovarian cancer	0.000481	0.0024	CcSEcCtD
Desloratadine—Abdominal pain—Vinorelbine—ovarian cancer	0.000481	0.0024	CcSEcCtD
Desloratadine—Connective tissue disorder—Docetaxel—ovarian cancer	0.00048	0.0024	CcSEcCtD
Desloratadine—Diarrhoea—Melphalan—ovarian cancer	0.000476	0.00238	CcSEcCtD
Desloratadine—Nausea—Chlorambucil—ovarian cancer	0.000474	0.00237	CcSEcCtD
Desloratadine—Dizziness—Topotecan—ovarian cancer	0.00047	0.00235	CcSEcCtD
Desloratadine—Increased appetite—Doxorubicin—ovarian cancer	0.000469	0.00234	CcSEcCtD
Desloratadine—Affect lability—Epirubicin—ovarian cancer	0.000468	0.00234	CcSEcCtD
Desloratadine—Agitation—Paclitaxel—ovarian cancer	0.000461	0.0023	CcSEcCtD
Desloratadine—Angioedema—Paclitaxel—ovarian cancer	0.000458	0.00229	CcSEcCtD
Desloratadine—Cardiac disorder—Docetaxel—ovarian cancer	0.000453	0.00226	CcSEcCtD
Desloratadine—Vomiting—Topotecan—ovarian cancer	0.000452	0.00226	CcSEcCtD
Desloratadine—Mood swings—Epirubicin—ovarian cancer	0.000451	0.00225	CcSEcCtD
Desloratadine—Rash—Topotecan—ovarian cancer	0.000448	0.00224	CcSEcCtD
Desloratadine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000448	0.00224	CcSEcCtD
Desloratadine—Dermatitis—Topotecan—ovarian cancer	0.000448	0.00224	CcSEcCtD
Desloratadine—Headache—Topotecan—ovarian cancer	0.000445	0.00223	CcSEcCtD
Desloratadine—Palpitations—Paclitaxel—ovarian cancer	0.000443	0.00221	CcSEcCtD
Desloratadine—Vomiting—Melphalan—ovarian cancer	0.000443	0.00221	CcSEcCtD
Desloratadine—Rash—Melphalan—ovarian cancer	0.000439	0.00219	CcSEcCtD
Desloratadine—Dermatitis—Melphalan—ovarian cancer	0.000439	0.00219	CcSEcCtD
Desloratadine—Cough—Paclitaxel—ovarian cancer	0.000437	0.00219	CcSEcCtD
Desloratadine—Asthenia—Vinorelbine—ovarian cancer	0.000436	0.00218	CcSEcCtD
Desloratadine—Convulsion—Paclitaxel—ovarian cancer	0.000434	0.00217	CcSEcCtD
Desloratadine—Affect lability—Doxorubicin—ovarian cancer	0.000433	0.00217	CcSEcCtD
Desloratadine—Pruritus—Vinorelbine—ovarian cancer	0.00043	0.00215	CcSEcCtD
Desloratadine—Breast disorder—Epirubicin—ovarian cancer	0.00043	0.00215	CcSEcCtD
Desloratadine—Mental disorder—Docetaxel—ovarian cancer	0.000428	0.00214	CcSEcCtD
Desloratadine—Myalgia—Paclitaxel—ovarian cancer	0.000427	0.00213	CcSEcCtD
Desloratadine—Nasopharyngitis—Epirubicin—ovarian cancer	0.000426	0.00213	CcSEcCtD
Desloratadine—Erythema—Docetaxel—ovarian cancer	0.000425	0.00212	CcSEcCtD
Desloratadine—Nausea—Topotecan—ovarian cancer	0.000422	0.00211	CcSEcCtD
Desloratadine—Dry mouth—Paclitaxel—ovarian cancer	0.000417	0.00209	CcSEcCtD
Desloratadine—Mood swings—Doxorubicin—ovarian cancer	0.000417	0.00208	CcSEcCtD
Desloratadine—Diarrhoea—Vinorelbine—ovarian cancer	0.000416	0.00208	CcSEcCtD
Desloratadine—Nausea—Melphalan—ovarian cancer	0.000414	0.00207	CcSEcCtD
Desloratadine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000409	0.00204	CcSEcCtD
Desloratadine—Oedema—Paclitaxel—ovarian cancer	0.000409	0.00204	CcSEcCtD
Desloratadine—Infection—Paclitaxel—ovarian cancer	0.000406	0.00203	CcSEcCtD
Desloratadine—Dizziness—Vinorelbine—ovarian cancer	0.000402	0.00201	CcSEcCtD
Desloratadine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000401	0.002	CcSEcCtD
Desloratadine—Tachycardia—Paclitaxel—ovarian cancer	0.000399	0.00199	CcSEcCtD
Desloratadine—Breast disorder—Doxorubicin—ovarian cancer	0.000398	0.00199	CcSEcCtD
Desloratadine—Bronchitis—Epirubicin—ovarian cancer	0.000396	0.00198	CcSEcCtD
Desloratadine—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000394	0.00197	CcSEcCtD
Desloratadine—Anorexia—Paclitaxel—ovarian cancer	0.00039	0.00195	CcSEcCtD
Desloratadine—Vomiting—Vinorelbine—ovarian cancer	0.000387	0.00193	CcSEcCtD
Desloratadine—Rash—Vinorelbine—ovarian cancer	0.000384	0.00192	CcSEcCtD
Desloratadine—Dermatitis—Vinorelbine—ovarian cancer	0.000383	0.00191	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000382	0.00191	CcSEcCtD
Desloratadine—Headache—Vinorelbine—ovarian cancer	0.000381	0.0019	CcSEcCtD
Desloratadine—Palpitations—Docetaxel—ovarian cancer	0.000375	0.00188	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000373	0.00186	CcSEcCtD
Desloratadine—Cough—Docetaxel—ovarian cancer	0.000371	0.00185	CcSEcCtD
Desloratadine—Insomnia—Paclitaxel—ovarian cancer	0.00037	0.00185	CcSEcCtD
Desloratadine—Convulsion—Docetaxel—ovarian cancer	0.000368	0.00184	CcSEcCtD
Desloratadine—Infestation NOS—Epirubicin—ovarian cancer	0.000367	0.00183	CcSEcCtD
Desloratadine—Infestation—Epirubicin—ovarian cancer	0.000367	0.00183	CcSEcCtD
Desloratadine—Bronchitis—Doxorubicin—ovarian cancer	0.000366	0.00183	CcSEcCtD
Desloratadine—Dyspnoea—Paclitaxel—ovarian cancer	0.000365	0.00182	CcSEcCtD
Desloratadine—Somnolence—Paclitaxel—ovarian cancer	0.000364	0.00182	CcSEcCtD
Desloratadine—Myalgia—Docetaxel—ovarian cancer	0.000362	0.00181	CcSEcCtD
Desloratadine—Nausea—Vinorelbine—ovarian cancer	0.000361	0.00181	CcSEcCtD
Desloratadine—Dyspepsia—Paclitaxel—ovarian cancer	0.00036	0.0018	CcSEcCtD
Desloratadine—Urinary tract infection—Epirubicin—ovarian cancer	0.000356	0.00178	CcSEcCtD
Desloratadine—Decreased appetite—Paclitaxel—ovarian cancer	0.000356	0.00178	CcSEcCtD
Desloratadine—Dry mouth—Docetaxel—ovarian cancer	0.000354	0.00177	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000354	0.00177	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000353	0.00176	CcSEcCtD
Desloratadine—Fatigue—Paclitaxel—ovarian cancer	0.000353	0.00176	CcSEcCtD
Desloratadine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000347	0.00173	CcSEcCtD
Desloratadine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000347	0.00173	CcSEcCtD
Desloratadine—Oedema—Docetaxel—ovarian cancer	0.000347	0.00173	CcSEcCtD
Desloratadine—Epistaxis—Epirubicin—ovarian cancer	0.000346	0.00173	CcSEcCtD
Desloratadine—Infection—Docetaxel—ovarian cancer	0.000345	0.00172	CcSEcCtD
Desloratadine—Nervous system disorder—Docetaxel—ovarian cancer	0.00034	0.0017	CcSEcCtD
Desloratadine—Infestation NOS—Doxorubicin—ovarian cancer	0.000339	0.0017	CcSEcCtD
Desloratadine—Infestation—Doxorubicin—ovarian cancer	0.000339	0.0017	CcSEcCtD
Desloratadine—Tachycardia—Docetaxel—ovarian cancer	0.000338	0.00169	CcSEcCtD
Desloratadine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000335	0.00167	CcSEcCtD
Desloratadine—Anorexia—Docetaxel—ovarian cancer	0.000331	0.00165	CcSEcCtD
Desloratadine—Urinary tract infection—Doxorubicin—ovarian cancer	0.00033	0.00165	CcSEcCtD
Desloratadine—Hepatitis—Epirubicin—ovarian cancer	0.000329	0.00164	CcSEcCtD
Desloratadine—Pharyngitis—Epirubicin—ovarian cancer	0.000327	0.00163	CcSEcCtD
Desloratadine—Urticaria—Paclitaxel—ovarian cancer	0.000325	0.00162	CcSEcCtD
Desloratadine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000324	0.00162	CcSEcCtD
Desloratadine—Abdominal pain—Paclitaxel—ovarian cancer	0.000323	0.00162	CcSEcCtD
Desloratadine—Body temperature increased—Paclitaxel—ovarian cancer	0.000323	0.00162	CcSEcCtD
Desloratadine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000321	0.0016	CcSEcCtD
Desloratadine—Epistaxis—Doxorubicin—ovarian cancer	0.00032	0.0016	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000316	0.00158	CcSEcCtD
Desloratadine—Insomnia—Docetaxel—ovarian cancer	0.000314	0.00157	CcSEcCtD
Desloratadine—Dyspnoea—Docetaxel—ovarian cancer	0.000309	0.00154	CcSEcCtD
Desloratadine—Somnolence—Docetaxel—ovarian cancer	0.000308	0.00154	CcSEcCtD
Desloratadine—Cardiac disorder—Epirubicin—ovarian cancer	0.000306	0.00153	CcSEcCtD
Desloratadine—Dyspepsia—Docetaxel—ovarian cancer	0.000305	0.00153	CcSEcCtD
Desloratadine—Hepatitis—Doxorubicin—ovarian cancer	0.000305	0.00152	CcSEcCtD
Desloratadine—Pharyngitis—Doxorubicin—ovarian cancer	0.000302	0.00151	CcSEcCtD
Desloratadine—Decreased appetite—Docetaxel—ovarian cancer	0.000301	0.00151	CcSEcCtD
Desloratadine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000301	0.00151	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000299	0.0015	CcSEcCtD
Desloratadine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000299	0.0015	CcSEcCtD
Desloratadine—Fatigue—Docetaxel—ovarian cancer	0.000299	0.00149	CcSEcCtD
Desloratadine—Asthenia—Paclitaxel—ovarian cancer	0.000294	0.00147	CcSEcCtD
Desloratadine—Pruritus—Paclitaxel—ovarian cancer	0.000289	0.00145	CcSEcCtD
Desloratadine—Mental disorder—Epirubicin—ovarian cancer	0.000288	0.00144	CcSEcCtD
Desloratadine—Erythema—Epirubicin—ovarian cancer	0.000287	0.00143	CcSEcCtD
Desloratadine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000284	0.00142	CcSEcCtD
Desloratadine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000283	0.00141	CcSEcCtD
Desloratadine—Diarrhoea—Paclitaxel—ovarian cancer	0.00028	0.0014	CcSEcCtD
Desloratadine—Abdominal pain—Docetaxel—ovarian cancer	0.000274	0.00137	CcSEcCtD
Desloratadine—Body temperature increased—Docetaxel—ovarian cancer	0.000274	0.00137	CcSEcCtD
Desloratadine—Dizziness—Paclitaxel—ovarian cancer	0.000271	0.00135	CcSEcCtD
Desloratadine—Mental disorder—Doxorubicin—ovarian cancer	0.000267	0.00133	CcSEcCtD
Desloratadine—Erythema—Doxorubicin—ovarian cancer	0.000265	0.00132	CcSEcCtD
Desloratadine—Agitation—Epirubicin—ovarian cancer	0.000263	0.00132	CcSEcCtD
Desloratadine—Vomiting—Paclitaxel—ovarian cancer	0.00026	0.0013	CcSEcCtD
Desloratadine—Rash—Paclitaxel—ovarian cancer	0.000258	0.00129	CcSEcCtD
Desloratadine—Dermatitis—Paclitaxel—ovarian cancer	0.000258	0.00129	CcSEcCtD
Desloratadine—Headache—Paclitaxel—ovarian cancer	0.000256	0.00128	CcSEcCtD
Desloratadine—Hypersensitivity—Docetaxel—ovarian cancer	0.000255	0.00128	CcSEcCtD
Desloratadine—Palpitations—Epirubicin—ovarian cancer	0.000253	0.00127	CcSEcCtD
Desloratadine—Cough—Epirubicin—ovarian cancer	0.00025	0.00125	CcSEcCtD
Desloratadine—Asthenia—Docetaxel—ovarian cancer	0.000249	0.00124	CcSEcCtD
Desloratadine—Convulsion—Epirubicin—ovarian cancer	0.000248	0.00124	CcSEcCtD
Desloratadine—Pruritus—Docetaxel—ovarian cancer	0.000245	0.00123	CcSEcCtD
Desloratadine—Myalgia—Epirubicin—ovarian cancer	0.000244	0.00122	CcSEcCtD
Desloratadine—Agitation—Doxorubicin—ovarian cancer	0.000244	0.00122	CcSEcCtD
Desloratadine—Nausea—Paclitaxel—ovarian cancer	0.000243	0.00121	CcSEcCtD
Desloratadine—Dry mouth—Epirubicin—ovarian cancer	0.000239	0.00119	CcSEcCtD
Desloratadine—Diarrhoea—Docetaxel—ovarian cancer	0.000237	0.00119	CcSEcCtD
Desloratadine—Palpitations—Doxorubicin—ovarian cancer	0.000234	0.00117	CcSEcCtD
Desloratadine—Oedema—Epirubicin—ovarian cancer	0.000234	0.00117	CcSEcCtD
Desloratadine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000234	0.00117	CcSEcCtD
Desloratadine—Infection—Epirubicin—ovarian cancer	0.000232	0.00116	CcSEcCtD
Desloratadine—Cough—Doxorubicin—ovarian cancer	0.000231	0.00116	CcSEcCtD
Desloratadine—Convulsion—Doxorubicin—ovarian cancer	0.00023	0.00115	CcSEcCtD
Desloratadine—Nervous system disorder—Epirubicin—ovarian cancer	0.000229	0.00115	CcSEcCtD
Desloratadine—Dizziness—Docetaxel—ovarian cancer	0.000229	0.00115	CcSEcCtD
Desloratadine—Tachycardia—Epirubicin—ovarian cancer	0.000228	0.00114	CcSEcCtD
Desloratadine—Myalgia—Doxorubicin—ovarian cancer	0.000226	0.00113	CcSEcCtD
Desloratadine—Anorexia—Epirubicin—ovarian cancer	0.000223	0.00111	CcSEcCtD
Desloratadine—Dry mouth—Doxorubicin—ovarian cancer	0.000221	0.0011	CcSEcCtD
Desloratadine—Vomiting—Docetaxel—ovarian cancer	0.00022	0.0011	CcSEcCtD
Desloratadine—Rash—Docetaxel—ovarian cancer	0.000219	0.00109	CcSEcCtD
Desloratadine—Dermatitis—Docetaxel—ovarian cancer	0.000218	0.00109	CcSEcCtD
Desloratadine—Headache—Docetaxel—ovarian cancer	0.000217	0.00109	CcSEcCtD
Desloratadine—Oedema—Doxorubicin—ovarian cancer	0.000216	0.00108	CcSEcCtD
Desloratadine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000216	0.00108	CcSEcCtD
Desloratadine—Infection—Doxorubicin—ovarian cancer	0.000215	0.00107	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000213	0.00106	CcSEcCtD
Desloratadine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000212	0.00106	CcSEcCtD
Desloratadine—Insomnia—Epirubicin—ovarian cancer	0.000212	0.00106	CcSEcCtD
Desloratadine—Tachycardia—Doxorubicin—ovarian cancer	0.000211	0.00106	CcSEcCtD
Desloratadine—Dyspnoea—Epirubicin—ovarian cancer	0.000209	0.00104	CcSEcCtD
Desloratadine—Somnolence—Epirubicin—ovarian cancer	0.000208	0.00104	CcSEcCtD
Desloratadine—Anorexia—Doxorubicin—ovarian cancer	0.000206	0.00103	CcSEcCtD
Desloratadine—Nausea—Docetaxel—ovarian cancer	0.000206	0.00103	CcSEcCtD
Desloratadine—Dyspepsia—Epirubicin—ovarian cancer	0.000206	0.00103	CcSEcCtD
Desloratadine—Decreased appetite—Epirubicin—ovarian cancer	0.000203	0.00102	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000202	0.00101	CcSEcCtD
Desloratadine—Fatigue—Epirubicin—ovarian cancer	0.000202	0.00101	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000197	0.000985	CcSEcCtD
Desloratadine—Insomnia—Doxorubicin—ovarian cancer	0.000196	0.000978	CcSEcCtD
Desloratadine—Dyspnoea—Doxorubicin—ovarian cancer	0.000193	0.000964	CcSEcCtD
Desloratadine—Somnolence—Doxorubicin—ovarian cancer	0.000192	0.000961	CcSEcCtD
Desloratadine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000191	0.000956	CcSEcCtD
Desloratadine—Dyspepsia—Doxorubicin—ovarian cancer	0.000191	0.000952	CcSEcCtD
Desloratadine—Decreased appetite—Doxorubicin—ovarian cancer	0.000188	0.00094	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000187	0.000934	CcSEcCtD
Desloratadine—Fatigue—Doxorubicin—ovarian cancer	0.000187	0.000932	CcSEcCtD
Desloratadine—Urticaria—Epirubicin—ovarian cancer	0.000186	0.000928	CcSEcCtD
Desloratadine—Abdominal pain—Epirubicin—ovarian cancer	0.000185	0.000924	CcSEcCtD
Desloratadine—Body temperature increased—Epirubicin—ovarian cancer	0.000185	0.000924	CcSEcCtD
Desloratadine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000177	0.000884	CcSEcCtD
Desloratadine—Hypersensitivity—Epirubicin—ovarian cancer	0.000172	0.000861	CcSEcCtD
Desloratadine—Urticaria—Doxorubicin—ovarian cancer	0.000172	0.000859	CcSEcCtD
Desloratadine—Body temperature increased—Doxorubicin—ovarian cancer	0.000171	0.000855	CcSEcCtD
Desloratadine—Abdominal pain—Doxorubicin—ovarian cancer	0.000171	0.000855	CcSEcCtD
Desloratadine—Asthenia—Epirubicin—ovarian cancer	0.000168	0.000838	CcSEcCtD
Desloratadine—Pruritus—Epirubicin—ovarian cancer	0.000165	0.000827	CcSEcCtD
Desloratadine—Diarrhoea—Epirubicin—ovarian cancer	0.00016	0.0008	CcSEcCtD
Desloratadine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000159	0.000797	CcSEcCtD
Desloratadine—Asthenia—Doxorubicin—ovarian cancer	0.000155	0.000776	CcSEcCtD
Desloratadine—Dizziness—Epirubicin—ovarian cancer	0.000155	0.000773	CcSEcCtD
Desloratadine—Pruritus—Doxorubicin—ovarian cancer	0.000153	0.000765	CcSEcCtD
Desloratadine—Vomiting—Epirubicin—ovarian cancer	0.000149	0.000743	CcSEcCtD
Desloratadine—Diarrhoea—Doxorubicin—ovarian cancer	0.000148	0.00074	CcSEcCtD
Desloratadine—Rash—Epirubicin—ovarian cancer	0.000147	0.000737	CcSEcCtD
Desloratadine—Dermatitis—Epirubicin—ovarian cancer	0.000147	0.000736	CcSEcCtD
Desloratadine—Headache—Epirubicin—ovarian cancer	0.000147	0.000732	CcSEcCtD
Desloratadine—Dizziness—Doxorubicin—ovarian cancer	0.000143	0.000715	CcSEcCtD
Desloratadine—Nausea—Epirubicin—ovarian cancer	0.000139	0.000694	CcSEcCtD
Desloratadine—Vomiting—Doxorubicin—ovarian cancer	0.000138	0.000688	CcSEcCtD
Desloratadine—Rash—Doxorubicin—ovarian cancer	0.000136	0.000682	CcSEcCtD
Desloratadine—Dermatitis—Doxorubicin—ovarian cancer	0.000136	0.000681	CcSEcCtD
Desloratadine—Headache—Doxorubicin—ovarian cancer	0.000136	0.000677	CcSEcCtD
Desloratadine—Nausea—Doxorubicin—ovarian cancer	0.000129	0.000642	CcSEcCtD
Desloratadine—Loratadine—ABCB1—ovarian cancer	3.32e-06	1	CrCbGaD
